Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/02/2003CA2479907A1 P-rex1, a ptdins (3, 4, 5) p3- g-beta-gamma-regulated guanine-nucleotide exchange factor for rac
10/02/2003CA2479901A1 Purification methods for oligonucleotides and their analogs
10/02/2003CA2479897A1 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003CA2479896A1 A mutated immunoglobulin-binding protein
10/02/2003CA2479879A1 Neisseria mutants, lipooligosaccharides and immunogenic compositions
10/02/2003CA2479858A1 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
10/02/2003CA2479739A1 Refined plant transformation
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479594A1 Pna oligomers, oligomer sets, methods and kits pertaining to the detection of bacillus anthracis
10/02/2003CA2479587A1 Nucleic acid constructs and methods for producing altered seed oil compositions
10/02/2003CA2479576A1 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003CA2479530A1 Hiv therapeutic
10/02/2003CA2479365A1 4-ketocarotenoids in flower petals
10/02/2003CA2479306A1 Egfr ligands and methods of use
10/02/2003CA2479167A1 Raav vector compositions and methods for the treatment of choroidal neovascularization
10/02/2003CA2479158A1 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003CA2478981A1 Identification of kinase inhibitors
10/02/2003CA2478957A1 Homogentisate prenyl transferase ("hpt") nucleic acids and polypeptides, and uses thereof
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478113A1 Modified promoter capable of functioning in a filamentous fungus
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/02/2003CA2466656A1 Bioconjugate-nanoparticle probes
10/01/2003EP1348963A1 Schizophrenia related gene
10/01/2003EP1348768A2 Method of treatment, diagnosis or detection of diabetes
10/01/2003EP1348767A2 Polymer chip and method for identifying an ionic polymer
10/01/2003EP1348766A1 Method and kit for detecting membrane protein-protein interactions
10/01/2003EP1348763A1 Sweet potato sporamin gene promoter
10/01/2003EP1348761A1 Marburg I mutant of factor VII activating protease (FSAP) as a risk factor for arterial thrombosis
10/01/2003EP1348760A2 Production of inactive mutants or mutants with a low activity of an alkaline phosphatase and their expression in yeast
10/01/2003EP1348758A1 Host cells having improved cell survival properties and methods to generate such cells
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348713A2 Labeling reagents and labeled tabeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
10/01/2003EP1348482A2 Modified solid carrier and DNA detection device
10/01/2003EP1348335A1 Non-human transgenic mammals and their use as a disease model
10/01/2003EP1348325A2 Solid matrix conditioning of seeds
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348035A2 Method for base sequencing and biologically active nucleic acids
10/01/2003EP1348034A2 Oligonucleotide identifiers
10/01/2003EP1348033A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
10/01/2003EP1348030A1 Viral vector for gene therapy
10/01/2003EP1348029A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/01/2003EP1348028A2 Substrate linked directed evolution (slide)
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1348020A1 An optical method for testing sensitivity of cells
10/01/2003EP1348019A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
10/01/2003EP1347993A2 Superficial zone protein and methods of making and using same
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347991A2 Amphipathic peptides and their use for transferring substances of interest into cells
10/01/2003EP1347833A2 Sample processing device and method
10/01/2003EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1347678A2 Method to maintain a genic male-sterile female parental lines for the production of hybrid wheat
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP0894146B1 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer metastasis formation
10/01/2003EP0868529B1 Method for detection of ki-ras mutations and kit to perform it
10/01/2003EP0846759B1 Gene encoding protein having asymmetric hydrolase activity on 4-substituted-1,4-dihydropyridine derivatives and expression product of the same
10/01/2003EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
10/01/2003EP0726946B1 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003EP0656940B1 Genetic sequences encoding glycosyltransferase enzymes and uses therefor
10/01/2003EP0638172B1 Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
10/01/2003EP0594678B1 Production of polyalkanoate
10/01/2003CN1446265A Means and method for monitoring antiretroviral therapy and guiding therapeutic decisions in treatment of HIV/AIDS
10/01/2003CN1446264A Method and device of testing nudein hybride pair on gene chip by four-dimensional paramerter
10/01/2003CN1446262A Molecular control of transgene segregation and its escape by cecoverable block of function (RBF) system
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446260A Lipoxygenase genes, promoters, transit peptides and protein thereof
10/01/2003CN1446259A Nucleotide sequences which code for lysR2 gene
10/01/2003CN1446258A Purification of triple heli formation with immobilized oligonucleotide
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446102A Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
10/01/2003CN1446050A Protein expression profiling
10/01/2003CN1445371A Constructing and building method for tabling gene and its application
10/01/2003CN1445370A Method for breeding transgene paddy rice with out choice mark by using dual T-DNA carrir
10/01/2003CN1445369A Technique of preparing and purifying antigen for testing primary biliary cirrhosis
10/01/2003CN1445368A Method for filtrating mutants of key gene against disease of plants
10/01/2003CN1445366A New protein kinase specific to human cardiac muscle and its coded sequence
10/01/2003CN1445359A Technique for artificial breeding Chinese caterpillar fungus with out polypide
10/01/2003CN1445243A Fab antibody of human resourced neutrality genetic engineering for anti human cytomegalo virus
10/01/2003CN1445242A Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition
10/01/2003CN1445241A Monochain antibody with dual specificities possessing activity for restraining adherence and aggregation of blood platelets
10/01/2003CN1445239A Mutain of human stem cell growth fcator as well as its preparing method and medicine combination
10/01/2003CN1445238A Conformation type peptide library based on insect alexins, its constitute method and application
10/01/2003CN1444996A Oral DNA combination for treating chronic infection of hepatitis B virus
10/01/2003CN1444992A Method and combination for treating tumors based on ERBB-3
10/01/2003CN1122719C Modified biological material
10/01/2003CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/01/2003CN1122717C Cyclodextrin glycosyltransferases for producing ganame cyclodextrin
10/01/2003CN1122716C Extracorporeal ceel culture and transplantation kits
10/01/2003CN1122530C Vacines
09/2003
09/30/2003US6629038 Marking individuals of commercially distributed organism or organisms and offspring thereof is disclosed. The method is effected by genetically marking a plurality of individuals of the organism or organisms with a plurality of unique DNA
1 ... 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 ... 4023